NCT01044706View on ClinicalTrials.gov

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

Bicalutamide

50 mg Oral Tablet

Trial Locations (1)

G1V 2K8

SFBC Anapharm, Sainte-Foy

Sponsors

Collaborators (1)

Watson Pharmaceuticals
All Listed Sponsors
collaborator

Watson Pharmaceuticals

INDUSTRY

lead

Kremers Urban Development Company

INDUSTRY

NCT01044706 - Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter